Get the Stockscreener App
19.16
0.93%
-0.18
After Hours:
19.16
Beta Bionics Inc stock is traded at $19.16, with a volume of 809.26K.
It is down -0.93% in the last 24 hours and down -13.65% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
See More
Previous Close:
$19.34
Open:
$19.38
24h Volume:
809.26K
Relative Volume:
0.78
Market Cap:
$1.03B
Revenue:
$110.24M
Net Income/Loss:
$-66.44M
P/E Ratio:
-12.68
EPS:
-1.5111
Net Cash Flow:
$-61.12M
1W Performance:
+17.19%
1M Performance:
-13.65%
6M Performance:
+67.63%
1Y Performance:
-4.27%
1-Day Range:
$18.81
$19.54
1-Week Range:
$16.60
$19.54
52-Week Range:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
19.16 | 1.03B | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-12-26 | Initiated | Jefferies | Buy |
| Oct-07-26 | Initiated | Barclays | Overweight |
| Sep-23-26 | Initiated | Wells Fargo | Overweight |
| Aug-21-26 | Initiated | William Blair | Mkt Perform |
| Jul-28-26 | Resumed | UBS | Buy |
| Feb-09-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Jan-09-26 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein - GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP - GlobeNewswire Inc.
BBNX DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BBNX ALERT: Bragar Eagel & Squire, P.C. Urges Beta Bionics, - GlobeNewswire
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026 - The Globe and Mail
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - Newport Daily Express
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lincoln Educational Services Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionLINC - GlobeNewswire Inc.
BBNX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure ... - Black Hills Pioneer
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baidu, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBIDU - GlobeNewswire Inc.
BBNX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tigo Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmTYGO - GlobeNewswire Inc.
Beta bionics CCO Mark Hopman sells $13,446 in shares - Investing.com
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc.BBNX - Morningstar
After selling 775 shares, Beta Bionics (BBNX) officer directly holds 55,334 shares. - Stock Titan
ROSEN, A LONGSTANDING FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP - GlobeNewswire Inc.
BBNX DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
Beta Bionics, Inc. Class Action ReminderRobbins LLP Encourages BBNX Investors to Contact the Firm for Information About Their Rights - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Beta Bionics, Inc. Notice of November 3, 2026 Application - GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
AEVEX Corp. Notice of October 20, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX - GlobeNewswire Inc.
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before the Securities Class Action Deadline on November 3, 2026 - The Globe and Mail
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
Markets & Stocks - FinancialContent
BBNX Shareholder Alert: November 3, 2026 Lead Plaintiff Deadline in Beta Bionics, Inc. Securities Class ActionContact Levi & Korsinsky - FinancialContent
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Chief commercial officer Hopman sells $7,015 of Beta Bionics stock By Investing.com - Investing.com Canada
Beta Bionics, Inc. (BBNX) stock price, news, quote and history - Yahoo Finance Australia
ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. - GlobeNewswire
Kaplan Fox Notifies Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of the Lead Plaintiff Deadline on November 3, 2026 - The Globe and Mail
BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action LawsuitHBSS - GlobeNewswire Inc.
BBNX ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
FinancialContentKaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)Deadline is November 3, 2026 - FinancialContent
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues DisclosedSecurities Fraud Class Action Filed - Lelezard
Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - Carroll County Mirror-Democrat
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - mykxlg.com
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - True North Radio Network
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beta Bionics Inc Stock (BBNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hopman Mark | Chief Commercial Officer |
Oct 01 '26 |
Sale |
18.96 |
370 |
7,015 |
56,109 |
| MARK HOPMAN | Officer |
Oct 01 '26 |
Proposed Sale |
18.98 |
2,660 |
50,487 |
0 |
| CHRISTINA JONES | Director |
Sep 22 '26 |
Proposed Sale |
22.04 |
8,942 |
197,082 |
0 |
| Jones Christy | Director |
Sep 22 '26 |
Sale |
23.00 |
6,430 |
147,890 |
19,564 |
| MARK HOPMAN | Officer |
Sep 16 '26 |
Proposed Sale |
19.23 |
28,119 |
540,728 |
0 |
| Mensinger Mike | Chief Product Officer |
Sep 16 '26 |
Sale |
22.00 |
2,650 |
58,300 |
177,390 |
| Hopman Mark | Chief Commercial Officer |
Sep 16 '26 |
Sale |
20.13 |
30,779 |
619,640 |
56,479 |
| MICHAEL MENSINGER | Officer |
Sep 16 '26 |
Proposed Sale |
19.23 |
5,300 |
101,919 |
0 |
| Hopman Mark | Chief Commercial Officer |
Sep 14 '26 |
Sale |
15.52 |
775 |
12,028 |
86,382 |
| Hopman Mark | Chief Commercial Officer |
Sep 09 '26 |
Sale |
18.46 |
36,870 |
680,723 |
87,157 |
0.99%
7.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):